/

/

Positive Data from Small Pharma's New Study Combining DMT & SSRIs

Tue, Sep 26

Perspectives

A new Phase Ib study from @SmallPharma explores interaction between SSRIs and the company’s DMT drug. The trial looked at patients with Major Depressive Disorder and initial results are positive. https://t.co/BLVVEbWJkH

8553

Topline results from Small Pharma's Phase Ib study exploring the interaction between SSRIs and SPL026, the company’s DMT drug.

Discover